Niacin-and-statin trial ends early; no benefit to raising HDL

National Institutes of HealthHealth
The NIH announced May 26 it has stopped a trial 18 months ahead of schedule after finding that combining extended-release, high-dose niacin with a statin doesn't seem to reduce the risk of adverse cardiovascular events like heart attacks and strokes. iStock photo
Loading